These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9934717)

  • 1. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States.
    Legler JM; Feuer EJ; Potosky AL; Merrill RM; Kramer BS
    Cancer Causes Control; 1998 Oct; 9(5):519-27. PubMed ID: 9934717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.
    Etzioni R; Berry KM; Legler JM; Shaw P
    Urology; 2002 Feb; 59(2):251-5. PubMed ID: 11834397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
    Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
    JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of increasing detection in the rising incidence of prostate cancer.
    Potosky AL; Miller BA; Albertsen PC; Kramer BS
    JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
    Etzioni R; Penson DF; Legler JM; di Tommaso D; Boer R; Gann PH; Feuer EJ
    J Natl Cancer Inst; 2002 Jul; 94(13):981-90. PubMed ID: 12096083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?
    Valberg M; Grotmol T; Tretli S; Veierød MB; Moger TA; Devesa SS; Aalen OO
    Eur J Epidemiol; 2017 Jun; 32(6):511-520. PubMed ID: 27431530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
    Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
    J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in prostate cancer mortality among black men and white men in the United States.
    Chu KC; Tarone RE; Freeman HP
    Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001.
    Sarma AV; Schottenfeld D
    Semin Urol Oncol; 2002 Feb; 20(1):3-9. PubMed ID: 11828352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey.
    Mariotto AB; Etzioni R; Krapcho M; Feuer EJ
    Cancer; 2007 May; 109(9):1877-86. PubMed ID: 17372918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973-1994.
    Schwartz KL; Severson RK; Gurney JG; Montie JE
    Cancer; 1996 Sep; 78(6):1260-6. PubMed ID: 8826949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.
    Collin SM; Martin RM; Metcalfe C; Gunnell D; Albertsen PC; Neal D; Hamdy F; Stephens P; Lane JA; Moore R; Donovan J
    Lancet Oncol; 2008 May; 9(5):445-52. PubMed ID: 18424233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics.
    Negoita S; Feuer EJ; Mariotto A; Cronin KA; Petkov VI; Hussey SK; Benard V; Henley SJ; Anderson RN; Fedewa S; Sherman RL; Kohler BA; Dearmon BJ; Lake AJ; Ma J; Richardson LC; Jemal A; Penberthy L
    Cancer; 2018 Jul; 124(13):2801-2814. PubMed ID: 29786851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rise and fall of radical prostatectomy rates from 1989 to 1996.
    Sheikh K; Bullock C
    Urology; 2002 Mar; 59(3):378-82. PubMed ID: 11880074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
    Welch HG; Albertsen PC
    J Natl Cancer Inst; 2009 Oct; 101(19):1325-9. PubMed ID: 19720969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality.
    Etzioni R; Legler JM; Feuer EJ; Merrill RM; Cronin KA; Hankey BF
    J Natl Cancer Inst; 1999 Jun; 91(12):1033-9. PubMed ID: 10379966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.
    Feuer EJ; Merrill RM; Hankey BF
    J Natl Cancer Inst; 1999 Jun; 91(12):1025-32. PubMed ID: 10379965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
    Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
    Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and prostate cancer screening among African-American and Caucasian men.
    Fowke JH; Signorello LB; Underwood W; Ukoli FA; Blot WJ
    Prostate; 2006 Sep; 66(13):1371-80. PubMed ID: 16752375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States.
    Howrey BT; Kuo YF; Lin YL; Goodwin JS
    J Gerontol A Biol Sci Med Sci; 2013 Jan; 68(1):56-61. PubMed ID: 22562961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.